杀菌性静血海绵:对抗创伤伤害的护理解决方案
Rajib Dey1, Riya Mukherjee1, Sudip Mukherjee1
1Antimicrobial Research Laboratory, New Chemistry Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Jakkur, Bengaluru, Karnataka, 560064, India.
Advanced healthcare materials
|January 17, 2025
概括
一种新型的杀菌性静血海绵 (BACSTAT) 有效地阻止出血,并对抗创伤伤中的感染. 这种先进的材料为军人和平民受伤提供了一个有前途的护理解决方案.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 伤口愈合 治愈 伤口愈合
背景情况:
- 创伤伤害由于不受控制的出血和微生物污染,存在重大风险.
- 有效的护理点止血解决方案对于治疗出血和预防感染至关重要.
- 开发具有结合止血和抗感染性质的材料仍然是一个重大挑战.
研究的目的:
- 开发一种可注射,杀菌的静血海绵,用于治疗创伤性伤口.
- 创建一个双交联材料,增强液体吸收和伤口密封能力.
- 评估新型海绵的静血,抗菌和生物相容性.
主要方法:
- 使用双重交联 (光聚合和纳米粒子相互作用) 制造一种基于纳米粒子的阴离子德克斯-半孔海绵 (BACSTAT).
- 评估液体吸收,形状恢复和伤口密封能力.
- 在小鼠模型中对血液静止的体内评估 (大腿静脉切口,肝脏穿刺).
- 测试广泛的抗菌活性和针对Pseudomonas aeruginosa的有效性.
- 评估与哺乳动物细胞和小鼠皮肤的生物相容性.
主要成果:
- 巴克斯塔特海绵表现出优异的液体吸收和快速的形状恢复,以有效地密封伤口.
- 在小鼠模型中观察到显著的静血疗效,促进血液快速凝固.
- 这种海绵在体内表现出强大的广泛抗菌活性,并减少了99%以上的细菌负担.
- 证实了与哺乳动物细胞和小鼠皮肤的完全生物相容性.
- 在受感染的组织中观察到减少了炎症反应.
结论:
- 开发的BACSTAT海绵是一种高效的静血和杀菌材料.
- 其独特的特性使其适合在护理地点立即应用.
- 作为军事和民用环境中创伤伤的治疗解决方案,BACSTAT具有显著的潜力.
相关概念视频
Introduction to Hemostasis
5.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.3K
Extrinsic and Intrinsic Pathways of Hemostasis
5.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.1K
Formation of the Platelet Plug
4.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.1K
Coagulation
4.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.4K
Clot Retraction and Fibrinolysis
3.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
606
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
606


